Gregory Rigano

@RiganoESQ

Research published by Elon Musk. ... , Account retired "Time is the longest distance between two places." Impossible is nothing.

present
Joined June 2018

Tweets

You blocked @RiganoESQ

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @RiganoESQ

  1. Pinned Tweet
    18 Mar 2020
    Replying to

    UPDATE: Full peer reviewed study has been released by Didier Raoult MD, PhD . After 6 days 100% of patients treated with HCQ + Azithromycin were virologically cured p-value <.0001

    Undo
  2. Retweeted
    16 Mar 2020
    Show this thread
    Undo
  3. Retweeted
    10 Jun 2020

    Corrélation entre liens déclarés avec Gilead sur et prises de positions publiques sur l'hydroxychloroquine.

    Undo
  4. Retweeted

    We shall not forget that the Surgisphere team did published a paper in the New England Journal of Medicine ; now retracted. This is not the only doubtful article edited by this journal during the current crisis.

    Undo
  5. Retweeted
    4 Jun 2020
    Replying to

    As a physician this sickens me. It shows that the highest minds in our field would suppress a therapy for political reasons. I thought we were supposed to be above that.

    Undo
  6. Retweeted

    BOOM. Lancet study on hydroxychloroquine retracted. Published study existed for only 13 days. Did Twitter peer-review result in the quickest retraction ever for a study of this magnitude?

    Show this thread
    Undo
  7. Retweeted

    As I said, every author of the Lancet and NEJM studies are denying seeing the data. I guess raw data in published studies was never that important.

    Undo
  8. Retweeted

    Open Letter to & author of the Surgisphere study () on HCQ signed by >100 doctors, profs & researchers. Data transparency is absolutely necessary for a study riddled with false data that resulted in HCQ trials cancelled worldwide.

    Show this thread
    Undo
  9. Retweeted
    27 May 2020

    Webcast of Crew Dragon’s demonstration mission with astronauts and on board the spacecraft is now live → 

    Undo
  10. Retweeted

    Latest censorship by YouTube is interview w/ Prof Karol Sikora (), former Chief of Cancer for the WHO. YouTube didn't like his analysis of serology testing, immunity and possibility that the virus is burning out. Interview can be seen at

    Undo
  11. Retweeted

    India offered HCQ prophylaxis to 10,000 Mumbai policemen. About 4,500 routinely took HCQ, while 5,500 refused. RESULTS: HCQ group: 0 deaths Non-HCQ group: 9 deaths And those who contracted COVID-19 in the HCQ group had "mild attacks" h/t

    Undo
  12. Retweeted

    MedicineUncensored is now LIVE and will be the new hub for BREAKING results of studies and the latest news on . (This site replaces my google doc compilation of HCQ and antibody studies.)

    Undo
  13. Retweeted

    Governement study about COVID-19 seroprevalence in Spain: among workers, those who had an "essential profession" and continued working were less infected than those staying at home. This should lead to a reflection on the role of general confinement.

    Undo
  14. Retweeted

    Another antibody study showing infections drastically underestimated, w/ a fatality rate of ~0.10%. IFR by age (Netherlands): 20-29 = 0.004% 30-39 = 0.007% 40-49 = 0.014% 50-59 = 0.10% 60-69 = 0.5% Compare to our flu-comparison chart below h/t

    Undo
  15. Retweeted
    12 May 2020

    Russia (145m people) has the 3rd highest number of Covid cases: 232,000. It has adopted hydroxychloroquine by decree on April 16. If HCQ is therapeutically active, a trend break in clinical outcomes should be visible by now. Here it is. Anecdotal still?

    Undo
  16. Retweeted

    New York Times just did a feature on 's research on hydroxychloroquine. Surprise surprise...the three "prominent French doctors" quoted criticizing Raoult's work are all either on Gilead's advisory board and/or receive funding from Gilead.

    Undo
  17. Retweeted

    FR + ENG Lecture critique de l'étude de Yu et al, MEDRXIV 2020 Critical analysis of the Yu and al. study, MEDRXIV 2020

    Undo
  18. Retweeted

    Publication de notre article : analyse retrospective du traitement de 1061 patients par HCQ/AZ. Publication of our paper : early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille

    Undo
  19. Retweeted

    Two major preprints have been published. Zhong Nanshan, hero of the 2003 SARS outbreak in China and his team: Hospital Central de la Defensa, Madrid: Both are strongly supporting the use of hydroxychloroquine for treating SARS-COV2

    Undo
  20. Retweeted
    4 May 2020

    Israel has decided to leave doctors free to treat with (hydroxy)chloroquine, whilst centralized France and the UK removed the right from non-hospital doctors at the start of the pandemic. Israeli practitioners zeroed in quickly on the solution. France and the UK face a disaster.

    Undo
  21. Retweeted
    2 May 2020

    The pandemic was sending as many patients into the Intensive Care Unit in the UK as in Italy. Italy has adopted the early hydroxychroloroquine treatment end of March. If it is therapeutically active, it MUST create a “trend break” reflecting better clinical outcomes. Here it is:

    Show this thread
    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·